Brian M Hoff
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antibiotic Use and Resistance 9
-
- Clostridium difficile and Clostridium perfringens research 2
- Tuberculosis Research and Epidemiology 1
- Co-authors
- Karen Marchillo (1 shared paper)Randall J. Massey (1 shared paper)Kathleen A. Holoyda (1 shared paper)Jeniel E. Nett (1 shared paper)David R. Andes (1 shared paper)William E. Dager (1 shared paper)Brett H. Heintz (1 shared paper)Stephen W. Zimmerman (1 shared paper)
- Journals
- Open Forum Infectious Diseases (5 papers)Infection Control and Hospital Epidemiology (2 papers)Antibiotics (1 paper)The American Journal of Medicine (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Brian M Hoff
16 papers receiving 537 citations
Peers
Comparison fields: 5 of 79
- Applied Microbiology and Biotechnology 51
- Infectious Diseases 278
- Periodontics 42
- Molecular Medicine 32
- Critical Care and Intensive Care Medicine 26
Countries citing papers authored by Brian M Hoff
This map shows the geographic impact of Brian M Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M Hoff more than expected).
Fields of papers citing papers by Brian M Hoff
This network shows the impact of papers produced by Brian M Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M Hoff. The network helps show where Brian M Hoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian M Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 315 | |
| 2 | 2019 | 100 | |
| 3 | 1979 | 41 | |
| 4 | 2019 | 32 | |
| 5 | 2018 | 19 | |
| 6 | 2018 | 15 | |
| 7 | 2018 | 9 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 3 | |
| 12 | 2018 | 3 | |
| 13 | 2022 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 0 |
About Brian M Hoff
Brian M Hoff is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Pharmacology, Epidemiology and Clinical Biochemistry, having authored 18 papers that have together received 557 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cystic Fibrosis Research Advances (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Nosocomial Infections in ICU (2 papers) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (51 citations), Infectious Diseases (278 citations), Periodontics (42 citations), Molecular Medicine (32 citations) and Critical Care and Intensive Care Medicine (26 citations). Brian M Hoff has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Karen Marchillo, Randall J. Massey, Kathleen A. Holoyda, Jeniel E. Nett, David R. Andes, William E. Dager, Brett H. Heintz, Stephen W. Zimmerman, Michihiko Goto and William K. Rogers. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Antibiotics, The American Journal of Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.